By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche today said that it has received US Food and Drug Administration clearance for the second-generation version its real-time PCR Cobas TaqMan HCV Test.

The test quantifies the amount of hepatitis C viral RNA in human plasma or serum of HCV-infected individuals. It incorporates a manual specimen preparation with Roche's Cobas TaqMan 48 Analyzer for automated amplification and detection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.